You have 9 free searches left this month | for more free features.

Dacryocystitis

Showing 1 - 25 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Color Doppler Ultrasound in Lacrimal Sac Space-occupying Lesions

Completed
  • Dacryocystitis; Chronic
  • +3 more
  • CDU and CT-DCG or CT examination
  • Wenzhou, Zhejiang, China
    Eye Hospital and School of Ophthalmology and Optometry,Wenzhou M
Aug 12, 2022

Epiphora, Dacryostenosis, Dacryocystitis Trial in New Orleans (Proparacaine Hydrochloride ophthalmic solution, USP 0.5%,

Recruiting
  • Epiphora
  • +2 more
  • Proparacaine Hydrochloride ophthalmic solution, USP 0.5%
  • Balanced salt solution
  • New Orleans, Louisiana
    Louisiana State University Health Sciences Center
Dec 15, 2022

Dacryocystitis Trial in Mansoura (Pregabalin 150mg, Placebo)

Completed
  • Dacryocystitis
  • Pregabalin 150mg
  • Placebo
  • Mansoura, Dakahlia, Egypt
    Department of Anesthesia, Mansoura University Hospitals
Jul 12, 2022

Epiphora, Dacryocystitis, Dacryocystocele Trial in Cairo (Endoscopic dacryocystorhinostomy)

Active, not recruiting
  • Epiphora
  • +2 more
  • Endoscopic dacryocystorhinostomy
  • Cairo, Egypt
    Ahmed ragab
Apr 2, 2021

Nasolacrimal Sac Biopsy in Endoscopic Dacryocystorhinostomy

Completed
  • Dacryocystitis; Chronic
  • biopsying
  • Cairo, Egypt
    Azhar faculty of medicine
Mar 9, 2021

Primary Open Angle Glaucoma Trial in Pessac (MIDI Arrow)

Completed
  • Primary Open Angle Glaucoma
  • MIDI Arrow
  • Pessac, France
    Clinique Mutualiste - Pavillon Ophtalmogique
Jun 22, 2021

Patient With Nasolacrimal Duct Obstruction, External Dacryocystorhinostomy Operation Trial in Mansoura (drug, procedure, other)

Not yet recruiting
  • Patient With Nasolacrimal Duct Obstruction
  • External Dacryocystorhinostomy Operation
  • Mansoura, DK, Egypt
    Mansoura University
Feb 6, 2022

Lacrimal Duct Obstruction Trial in Hangzhou (Low temperature plasma lacrimal duct obstruction ablation combined with lacrimal

Recruiting
  • Lacrimal Duct Obstruction
  • Low temperature plasma lacrimal duct obstruction ablation combined with lacrimal duct catheterization
  • YAG lacrimal duct laser combined with lacrimal duct catheter
  • Hangzhou, China
    Second Affiliated Hospital of Zhejiang University Hospital
Jun 27, 2021

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis Trial in Worldwide

Completed
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • +2 more
  • Los Angeles, California
  • +37 more
Feb 18, 2022

Congenital Nasolacrimal Duct Obstruction Trial in Tehran (Endoscopy Assisted Probing procedure)

Unknown status
  • Congenital Nasolacrimal Duct Obstruction
  • Endoscopy Assisted Probing procedure
  • Tehran, Iran, Islamic Republic of
    Farzad Pakdel
Oct 9, 2019

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

Malignant Tumor of Breast Trial in Japan (DS-8201a)

Completed
  • Malignant Neoplasm of Breast
  • Yokohama, Kanagawa, Japan
  • +6 more
Mar 17, 2022

Dacryocystitis, Bacteriology Trial in Guangzhou (bacterial culture and analysis)

Unknown status
  • Dacryocystitis
  • Bacteriology
  • bacterial culture and analysis
  • Guangzhou, Guangdong, China
    Clinical Research Center
Jul 26, 2017

Gastric Cancer Trial in Japan, Korea, Republic of (TAS-118 plus Oxaliplatin, S-1 plus Cisplatin)

Completed
  • Gastric Cancer
  • TAS-118 plus Oxaliplatin
  • S-1 plus Cisplatin
  • Ibaraki, Japan
  • +5 more
Nov 10, 2021

Advanced BRAFV600 Wild-type Melanoma Trial in Worldwide (Cobimetinib, Atezolizumab, Pembrolizumab)

Terminated
  • Advanced BRAFV600 Wild-type Melanoma
  • Tucson, Arizona
  • +120 more
Aug 24, 2022

Nasal and Pharyngeal Microbiome Trial in Vienna (Gentamicin Ophthalmic, Ciprofloxacin Ophthalmic, Povidone Ophthalmic)

Recruiting
  • Nasal and Pharyngeal Microbiome
  • Gentamicin Ophthalmic
  • +3 more
  • Vienna, Austria
    Department of Clinical Pharmacology, Medical University of Vienn
Mar 10, 2022

Endonasal Dacryocystorhinostomy and Evolution of the Stoma Size

Completed
  • Endonasal Dacryocystorhinostomy
    • (no location specified)
    Aug 12, 2019

    Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Enzalutamide, Docetaxel, Prednisolone)

    Active, not recruiting
    • Metastatic Castration Resistant Prostate Cancer
    • Linz, Austria
    • +88 more
    Dec 22, 2022

    Patients With Corneal and External Diseases

    Completed
    • Blepharitis
    • +5 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jun 30, 2017

      Refractory Diffuse Large B Cell Lymphoma Trial in United States (KTE-C19, Atezolizumab, Cyclophosphamide)

      Active, not recruiting
      • Refractory Diffuse Large B Cell Lymphoma
      • KTE-C19
      • +3 more
      • Duarte, California
      • +4 more
      Apr 27, 2022

      Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

      Active, not recruiting
      • Chronic Myelogenous Leukemia
      • Nilotinib followed by treatment-free
      • Fort Myers, Florida
      • +113 more
      Apr 25, 2022

      Chronic GVHD Trial in Worldwide (ibrutinib, Placebo, Prednisone)

      Completed
      • Chronic Graft Versus Host Disease
      • Scottsdale, Arizona
      • +101 more
      Jan 24, 2022

      Active Dermatomyositis Trial in Czechia, Japan, United States (BAF312, Placebo)

      Terminated
      • Active Dermatomyositis
      • Phoenix, Arizona
      • +8 more
      Dec 9, 2020

      Rheumatoid Arthritis Trial in Worldwide (SAR153191 (REGN88))

      Completed
      • Rheumatoid Arthritis
      • SAR153191 (REGN88)
      • Anniston, Alabama
      • +334 more
      Mar 21, 2022

      Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

      Active, not recruiting
      • Breast Cancer
      • Mobile, Alabama
      • +437 more
      Mar 21, 2022